Articles From: - JetBlue and EL AL Israel Airlines Announce Plans to Codeshare to - INVESTOR ALERT: Investigation on Behalf of AcelRx Pharmaceuticals, Inc. Shareholders Announced by Glancy Binkow & Goldberg LLP


http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=11G022658-001&sourceType=1 NEW YORK, NY and TEL AVIV, ISRAEL--(Marketwired - September 29, 2014) - EL AL Israel Airlines and JetBlue Airways (NASDAQ: JBLU) today filed with the United States Department of Transportation seeking approval to codeshare.
Sign-up for - JetBlue and EL AL Israel Airlines Announce Plans to Codeshare investment picks
Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentation of data on the investigational use of KEYTRUDA ® (pembrolizumab) – the company’s anti-PD-1 therapy – in PD-L1 positive, advanced urothelial cancer (also known as bladder cancer). The early findings presented showed a confirmed overall response rate of 24 percent with KEYTRUDA as monotherapy, as measured by RECIST v1.1, central review (n= 7/29: 95% CI, 10.3-43.5) including a complete response rate of 10 percent (3/29). At the time of analysis, response durations ranged from 16+ to 40+ weeks with six of the seven responders continuing on therapy.
Sign-up for - Merck Announces First Presentation of Early Data on the Investigational Use of KEYTRUDA® (pembrolizumab) in Patients with Advanced Bladder Cancer at ESMO 2014 investment picks
Bristol-Myers Squibb Company (NYSE:BMY) today announced positive results from CheckMate -037, a Phase 3 randomized, controlled open-label study of Opdivo (nivolumab), an investigational PD-1 immune checkpoint inhibitor, versus investigator’s choice chemotherapy (ICC) in patients with advanced melanoma who were previously treated with Yervoy (ipilimumab). Based on a planned interim analysis of the co-primary endpoint, the objective response rate (ORR) was 32% (95% CI = 24, 41) in the Opdivo arm (n=120) and 11% (95% CI = 4, 23) in the ICC reference arm (n=47) in patients with at least six months of follow up.
Sign-up for - Positive Phase 3 Data for Opdivo (nivolumab) in Advanced Melanoma Patients Previously Treated with Yervoy (ipilimumab) Presented at the ESMO 2014 Congress; First Phase 3 Results Presented for a PD-1 Immune Checkpoint Inhibitor investment picks
2014/09/29
Current valuation levels imply mediocre total returns and an elevated risk of a material drawdown.
Sign-up for 2014/09/29 - Stock Market Outlook: Keep Your Expectations in Check investment picks
2014/9/29
Winners to be Announced December 11 in New York City at Black-Tie Event NEW YORK , Sept.
Sign-up for 2014/9/29 - Finalists from 26 Countries Vie for 2014 Platts Global Energy Awards investment picks
MILWAUKEE, Sept.
Sign-up for - Jason Industries, Inc. Announces Dividend on Preferred Stock investment picks
2014/9/29
Levi & Korsinsky announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of investors who purchased EDAP TMS S.A. (“EDAP” or the “Company”) (NasdaqGM:EDAP) common stock between February 1, 2013 and July 30, 2014.
Sign-up for 2014/9/29 - UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action against EDAP TMS S.A. and Its Board of Directors and a Lead Plaintiff Deadline of October 3, 2014 investment picks
Merger discussions between Hollywood studio DreamWorks Animation SKG Inc. (DWA) and Japan telecom SoftBank Corp.
Sign-up for - Talks cooling between DreamWorks, SoftBank, report says investment picks
Mavenir Systems® (NYSE:MVNR), a leading provider of software-based networking solutions, announced today that it won the Network Functions Virtualization (NFV) award for its ‘Virtualized RCS based on NFV’ live solution at the LTE Asia conference in Singapore.
Sign-up for - Mavenir Systems® Wins NFV Award investment picks
2014/9/29
Rising customer expectations and more channels of interaction continue to drive the customer revolution, forcing organizations to rethink their customer experience strategies.
Sign-up for 2014/9/29 - Perficient Delivers Customer Experience Solutions Designed to Drive Growth, Profitability for Clients investment picks
Monday, September 29, 2014 the Board of Directors of Dreyfus Strategic Municipal Bond Fund, Inc. (NYSE:DSM) declared from net investment income a monthly cash dividend of $0.0475 per share of common stock, payable on October 31, 2014, to shareholders of record at the close of business on October 14, 2014.
Sign-up for - Dreyfus Strategic Municipal Bond Fund, Inc. (NYSE: DSM) Declares Dividend investment picks
WGL Holdings, Inc. (NYSE: WGL), the parent company of Washington Gas and other energy-related subsidiaries, today announces the election of Dale S.
Sign-up for - Dale S. Rosenthal Elected to Boards of Directors of WGL Holdings, Inc. and Washington Gas investment picks
http://media.marketwire.com/attachments/201101/18059_289446_NEWCISCO.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147927&ProfileId=051205&sourceType=1 SAN JOSE, CA --
Sign-up for - Cisco Completes Acquisition of Metacloud investment picks
Chambers Street Properties (NYSE:CSG), a real estate investment trust focused on acquiring, owning and operating net leased industrial and office properties, today announced that the Company will release financial results for the third quarter ended September 30, 2014 before market open on October 30, 2014.
Sign-up for - Chambers Street Announces Third Quarter Earnings Release and Conference Call investment picks
Seeks to Remove, for Cause, Directors William Grieco, Vincent Enright and James Smith Files Preliminary Proxy Statement with SEC Calls on Directors to Resign from Board Immediately NEW YORK , Sept.
Sign-up for - Platinum Management (NY) LLC Calls for a Special Meeting of Stockholders at Echo Therapeutics, Inc. investment picks
Analog Devices, Inc. (NASDAQ: ADI ), a global leader in high-performance semiconductors for signal processing applications, today announced that Ali Husain, Director of Investor Relations, presented at the recent Morningstar ‘Management Behind the Moat’ Conference in Chicago.
Sign-up for - Analog Devices Discusses Strategy to Drive Diversified Growth and Shareholder Returns at the 2014 Morningstar ‘Management behind the Moat’ Conference investment picks
The Rosen Law Firm, P.A. announces that it is investigating the Board of Directors of TIBCO Software Inc. (NASDAQ:TIBX) for possible breaches of fiduciary duty and other violations of law by failing to adequately shop TIBCO to maximize shareholder value before agreeing to be acquired by Vista Equity Partners, a private equity firm.
Sign-up for - EQUITY ALERT: Rosen Law Firm Announces Investigation of TIBCO Software Inc. Concerning its Proposed Sale to Vista Equity Partners – TIBX investment picks
2014/9/29
NEW YORK , Sept.
Sign-up for 2014/9/29 - XL Group's North America Property Business Adds Insurance Leader in Dallas investment picks
First Interstate BancSystem, Inc. (NASDAQ: FIBK), parent company of First Interstate Bank and Mountain West Bank NA, will report third quarter results after the market closes on Monday, October 27, 2014.
Sign-up for - First Interstate BancSystem, Inc. Announces Third Quarter Earnings Release and Conference Call investment picks
MEDIA ADVISORY, Sept.
Sign-up for - AppliedMicro to Launch New Line of Embedded Products at ARM TechCon 2014 investment picks
2014/9/29
The Lone Star State has a new reason to claim that “everything’s bigger in Texas.” In a more than half-a-billion-dollar order, Exelon, one of the largest competitive U.S. power generators, turned to GE (NYSE:GE) to purchase four 7HA gas turbines, two D600 steam turbines, six generators and a contractual service agreement for the Wolf Hollow and Colorado Bend gas combined-cycle projects.
Sign-up for 2014/9/29 - Exelon Orders GE’s H-Class Gas Turbines—the World’s Largest and Most Efficient—for U.S. Combined-Cycle Power Projects investment picks
Exelis ( NYSE: XLS ) has received official certification for its AN/ALQ-211(V)9 Advanced Integrated Defensive Electronic Warfare System (AIDEWS) to fly on board Pakistani F-16 fighter aircraft.
Sign-up for - Exelis electronic countermeasures pod certified for installation on international F-16 Fighting Falcons investment picks
2014/9/29
The signature transmission project in Xcel Energy’s Power for the Plains grid improvement plan for Texas and New Mexico is now in service, providing a host of benefits to communities across the area, as well as to the industries that underpin the regional economy.
Sign-up for 2014/9/29 - Xcel Energy Powers Up Texas Segment of TUCO-Woodward Electric Transmission Line investment picks
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147709&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for - Oracle Announces Exalytics In-Memory Machine X4-4 investment picks
http://media.marketwire.com/attachments/200906/438886_oracleresized.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147710&ProfileId=051205&sourceType=1 SAN FRANCISCO, CA --
Sign-up for - Oracle Highlights Continued Java SE Momentum and Innovation at JavaOne 2014 investment picks
http://media.marketwire.com/attachments/201205/45309_43733_HP_Blue_RGB_72_MD.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1147581&ProfileId=051205&sourceType=1 PALO ALTO, CA and PHILADELPHIA, PA --
Sign-up for - HP Helps Home Offices Get Neat investment picks
Glancy Binkow & Goldberg LLP announces that it is investigating potential claims on behalf of purchasers of the securities of AcelRx Pharmaceuticals, Inc. (“AcelRx” or the “Company”) (NASDAQ:ACRX) concerning possible violations of federal securities laws.
Sign-up for - INVESTOR ALERT: Investigation on Behalf of AcelRx Pharmaceuticals, Inc. Shareholders Announced by Glancy Binkow & Goldberg LLP investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: - JetBlue and EL AL Israel Airlines Announce Plans to Codeshare to - INVESTOR ALERT: Investigation on Behalf of AcelRx Pharmaceuticals, Inc. Shareholders Announced by Glancy Binkow & Goldberg LLP
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent